Search tool

Displaying 81 - 90 of 999

ESPAD upcoming report

Upcoming ESPAD report on substance use among school students

The latest European data on substance use among 15–16-year-old school students will be released next week (20 September). The findings are based on a 2015 survey in 35 European countries

European Parliament building

EMCDDA Director presents the European Drug Report 2016 to members of the Civil Liberties, Justice and Home Affairs (LIBE) Committee of the European Parliament

The Director will present the European Drug Report 2016 on 8 September 2016 to the members of the Civil Liberties, Justice and Home Affairs (LIBE) Committee of the European Parliament. The presentation...

EDMR brochure cover

EU Drug Markets Report: promotional brochure

This brochure offers an overview of the latest EU Drug Markets Report, from the EMCDDA and Europol. Published every three years, the report provides a state-of-the-art analysis of the illicit drug market...

NPS

New psychoactive substances: Commission proposes new ban and strengthens the EU's Early Warning System and risk assessment

Today, the European Commission has proposed to subject the new psychoactive substance MDMB-CHMICA (sometimes referred to as ‘Black Mamba’) to control measures across the European Union.

Publication thumbnail

Hospital emergency presentations and acute drug toxicity in Europe — update from the Euro-DEN Plus research group and the EMCDDA

This rapid communication provides an update on drug related hospital emergency presentations in Europe with a specific focus on the latest results for acute drug toxicity presentations to the European Drug Emergencies...

Picture ambulance

New EMCDDA report sheds light on drug-related hospital emergencies

Data from hospital emergency departments show that every year in Europe thousands of individuals experience drug-related poisoning and other harms, requiring some kind of medical assistance.

Publication thumbnail

Hepatitis C among drug users in Europe: epidemiology, treatment and prevention

Hepatitis C among drug users in Europe: epidemiology, treatment and prevention provides a timely contribution to raising awareness of the hepatitis C epidemic in Europe and the opportunities now opening up to...

Close-up of virus

New EMCDDA report shows grounds for hope in treating hepatitis C

Hepatitis C is an infectious disease of the liver caused by the blood-borne hepatitis C virus. In a new report published today on World Hepatitis Day, the EU drugs agency (EMCDDA) looks...

Risk assessment α-PVP thumbnail

Report on the risk assessment of 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP)

This publication presents the data and findings of the risk assessment on α-PVP (1-phenyl- 2-(1-pyrrolidinyl)-1-pentanone), carried out by the extended Scientific Committee of the EMCDDA on 18 November 2015. α-PVP is the...

Libe Committée visit 2016

European Parliament LIBE Committee members pay fact-finding visit to the EMCDDA

Members of the European Parliament Committee on Civil Liberties, Justice and Home Affairs (LIBE) start a two-day visit to the EMCDDA today where they will hear presentations on the agency’s contribution to...